• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New ‘carbs study’ shows salacia extract helps curb appetite and manage blood sugar

Bioengineer by Bioengineer
August 30, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: OmniActive

Morristown, N.J., Aug. 30, 2017 – In the recent CARBS (an acronym for Carbohydrate, Appetite Reduction, Blood Sugar and Satiety) study, researchers at Rutgers University observed that a proprietary salacia extract demonstrated appetite reduction, satiety and blood sugar management benefits. Native to the Indian subcontinent, salacia is a genus of woody climbers well known for its traditional use in Ayurveda as a medicinal food supplement for various health conditions. The recent paper, Appetite and gut hormones response to a putative α-glucosidase inhibitor, Salacia chinensis, in overweight/obese adults: a double blind randomized controlled trial, published in the journal Nutrients discussed the findings of the CARBS (an acronym for Carbohydrate, Appetite Reduction, Blood Sugar and Satiety) Study.

CARBS was a randomized, double blind, placebo-controlled, 3-way cross-over study and the first to examine the effects of a proprietary extract of Salacia chinensis (from OmniLean) on glycemic indices and gut hormones after a meal. OmniLean, taken with a meal, resulted in an improved glycemic response and changes in gut hormones in healthy overweight/obese individuals, thereby reducing blood sugar spikes and impacting appetite and satiety.

"The herb, Salacia chinensis, was shown to reduce glycemic indices and affect gut peptides after a meal. What does this mean? It means Salacia chinensis from OmniLean may be an appetite modulator, and because it lowers glycemic indices, would be beneficial to persons at risk for diabetes including overweight/obese person," said Sue A. Shapses, Ph.D., R.D., one of the lead researchers on the CARBS Study.

This type of research is good news considering the latest, startling statistics on the obesity pandemic. A 2017 report by CNN stated that one-third of the people in the world are currently obese or overweight, and if this trend continues, it has been estimated that almost half of the global population may be obese or overweight 2030 (Global Panel on Agriculture and Food Systems for Nutrition).

"The myriad complexities of being overweight need to be addressed by a multipronged approach including diet and exercise, but may also benefit greatly by making a small change such as incorporating a natural supplement like OmniLean to your daily regiment," said Abhijit Bhattacharya, President of OmniActive Health Technologies Ltd., producers of OmniLean Salacia Extract. "The CARBS Study demonstrated that OmniLean reduced the feeling of hunger and reduced spikes in blood sugar — key components of weight management — which may be the missing piece for a vast population struggling with maintaining a healthy weight."

###

For more information on the CARBS Study or OmniLean, please contact Sara Zoet at [email protected].

Media Contact

Christopher Andraka
[email protected]
908-500-1737
@OmniActive_Life

http://omniactives.com/

Share12Tweet8Share2ShareShareShare2

Related Posts

Temperature Fluctuations Have Greater Impact Than Previously Believed

July 10, 2026
New Study Uncovers Biology Behind Glioma Cancer Progression

New Study Uncovers Biology Behind Glioma Cancer Progression

July 10, 2026

Ecological Limits and Functions in Microbiome-Based Integrative Medicine

July 10, 2026

New Therapy Accelerates Bone Marrow Recovery by Targeting Microenvironment

July 10, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Uremic Toxins Drive Kidney Fat Synthesis and Fibrosis Through AhR Activation

Durable CNT@Ag-MXene Sensor Resists Corrosion Under High Strain

IBEC Joins Major European Grant on Living Matter Physics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 84 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.